全文获取类型
收费全文 | 387936篇 |
免费 | 50489篇 |
国内免费 | 16755篇 |
专业分类
耳鼻咽喉 | 7164篇 |
儿科学 | 8314篇 |
妇产科学 | 7232篇 |
基础医学 | 31135篇 |
口腔科学 | 5644篇 |
临床医学 | 56779篇 |
内科学 | 85788篇 |
皮肤病学 | 10081篇 |
神经病学 | 27803篇 |
特种医学 | 14689篇 |
外国民族医学 | 96篇 |
外科学 | 66378篇 |
综合类 | 34280篇 |
现状与发展 | 117篇 |
一般理论 | 45篇 |
预防医学 | 21903篇 |
眼科学 | 9927篇 |
药学 | 25013篇 |
164篇 | |
中国医学 | 10896篇 |
肿瘤学 | 31732篇 |
出版年
2024年 | 1359篇 |
2023年 | 7964篇 |
2022年 | 9793篇 |
2021年 | 14334篇 |
2020年 | 14111篇 |
2019年 | 9580篇 |
2018年 | 15028篇 |
2017年 | 14020篇 |
2016年 | 14736篇 |
2015年 | 18165篇 |
2014年 | 27724篇 |
2013年 | 27023篇 |
2012年 | 22711篇 |
2011年 | 24413篇 |
2010年 | 21736篇 |
2009年 | 23232篇 |
2008年 | 18314篇 |
2007年 | 16628篇 |
2006年 | 18630篇 |
2005年 | 16017篇 |
2004年 | 11483篇 |
2003年 | 9517篇 |
2002年 | 8579篇 |
2001年 | 9730篇 |
2000年 | 9073篇 |
1999年 | 9577篇 |
1998年 | 7255篇 |
1997年 | 7089篇 |
1996年 | 6121篇 |
1995年 | 5764篇 |
1994年 | 4153篇 |
1993年 | 3046篇 |
1992年 | 3652篇 |
1991年 | 3391篇 |
1990年 | 2711篇 |
1989年 | 2616篇 |
1988年 | 2271篇 |
1987年 | 2020篇 |
1986年 | 1821篇 |
1985年 | 1457篇 |
1984年 | 1034篇 |
1983年 | 897篇 |
1982年 | 736篇 |
1981年 | 598篇 |
1980年 | 547篇 |
1979年 | 548篇 |
1978年 | 469篇 |
1977年 | 508篇 |
1975年 | 362篇 |
1972年 | 375篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Fur-Hsing Wen Jen-Shi Chen Wen-Chi Chou Wen-Cheng Chang Wen Chi Shen Chia-Hsun Hsieh Siew Tzuh Tang 《Journal of pain and symptom management》2019,57(1):64-72
Context
Family caregivers constitute a critical component of the end-of-life care system with considerable cost to themselves. However, the joint association of terminally ill cancer patients' symptom distress and functional impairment with caregivers' subjective caregiving burden, quality of life (QOL), and depressive symptoms remains unknown.Objectives/Methods
We used multivariate hierarchical linear modeling to simultaneously evaluate associations between five distinct patterns of conjoint symptom distress and functional impairment (symptom-functional states) and subjective caregiving burden, QOL, and depressive symptoms in a convenience sample of 215 family caregiver–patient dyads. Data were collected every 2 to 4 weeks over patients' last 6 months.Results
Caregivers of patients in the worst symptom-functional states (States 3–5) reported worse subjective caregiving burden and depressive symptoms than those in the best two states, but the three outcomes did not differ between caregivers of patients in State 3 and States 4–5. Caregivers of patients in State 5 endured worse subjective caregiving burden and QOL than those in State 4. Caregivers of patients in State 4 suffered worse subjective caregiving burden and depressive symptoms but comparable QOL to those in State 2.Conclusion
Patients' five distinct, conjoint symptom-functional states were significantly and differentially associated with their caregivers' worse subjective caregiving burden, QOL, and depressive symptoms while caring for patients over their last 6 months. 相似文献12.
AbstractBackground: This study aims to compare the effectiveness of inhaled prostacyclin or its analoguesversus nitric oxide (NO) in treating pulmonary hypertension (PH) after cardiac or pulmonary surgery remains unclear.Methods: PubMed, Cochrane, and Embase databases were searched for literature published prior to December 2019 using the following keywords: inhaled, nitric oxide, prostacyclin, iloprost, treprostinil, epoprostenol, Tyvaso, flolan, and pulmonary hypertension. Randomized controlled trials and multiple-armed prospective studies that evaluated inhaled NO versus prostacyclin (or analogues) in patients for perioperative and/or postoperative PH after either cardiac or pulmonary surgery were included. Retrospective studies, reviews, letters, comments, editorials, and case reports were excluded.Results: Seven studies with a total of 195 patients were included. No difference in the improvement of mean pulmonary arterial pressure (pooled difference in mean change= ?0.10, 95% CI: ?3.98 to 3.78, p?=?.959) or pulmonary vascular resistance (pooled standardized difference in mean change= ?0.27, 95% CI: ?0.60 to 0.05, p?=?.099) were found between the two treatments. Similarly, no difference was found in other outcomes between the two treatments or subgroup analysis.Conclusions: Inhaled prostacyclin (or analogues) was comparable to inhaled NO in treating PH after cardiac or pulmonary surgery.
- Key messages
This study compared the efficacy of inhaled prostacyclin or its analogues versus inhaled NO to treat PH after surgery. The two types of agent exhibited similar efficacy in managing MPAP, PVR, heart rate, and cardiac output was observed.
Inhaled prostacyclin may serve as an alternative treatment option for PH after cardiac or pulmonary surgery.
13.
近年来,血管外科腔内治疗手段飞速发展和进步,因其创伤小、并发症少、术后恢复快及对患者一般情况要求较宽松等优势,使得很多临床医生和患者更倾向于通过腔内手段治疗血管疾病,逐渐忽视了外科手术治疗的重要性,甚至出现忽视患者病情的个体情况而盲目选择腔内治疗的趋势。作为血管疾病治疗的重要方式,开放手术乃是血管外科的立家之本,是血管外科临床医生的基本技能,在很多情况下有着不可替代的作用,应当再次被强调、被重视。 相似文献
14.
15.
16.
18.
Although psychoanalysis was the first-choice treatment for premature ejaculation (PE) between 1920 and 1960, hardly any reports on its efficacy have been published. Moreover, a scientific debate about its findings has never been fully developed. The recent progress that has been made in the classification of three different PE syndromes creates a new opportunity for psychoanalytic investigations of men with complaints of PE, distinguished by the actual duration of their intravaginal ejaculation latency time (IELT). The term premature-like ejaculatory dysfunction has been introduced to distinguish men with self-perceived PE at normal and long IELT durations from those men with lifelong, acquired and normal variable PE. Psychoanalytic research may contribute to a better understanding of the consequences of objective early ejaculations on the unconscious mental life of men with the four forms of PE. By integrating neurobiological, clinical and epidemiological data of ejaculatory performance, a revival of psychoanalytic research of PE in the four distinct, classified PE groups, will probably contribute to a deeper insight in to the unconscious mental life of men affected by PE. 相似文献
19.
20.
Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves
a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because
of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address
issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment
should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these
are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating
a successful pharmacologic treatment program for patients with fibromyalgia. 相似文献